glp 1 semaglutide and tirzepatide vs for Weight Loss The GLP-1 family, explained for

Retatrutide targets three pathways, while tirzepatide targets two

Key metabolic pathways affected Semaglutide does more than control blood sugar levels

This is because the medication is FDA-approved for diabetes treatment

Follow the dose-escalation schedule to reduce the risk of gastrointestinal adverse reactions

Saxenda Saxenda is FDA-approved for chronic weight management when used as an adjunct to dietary modifications and increased physical activity in patients aged 12 or more with: Obesity, with BMI that cuts off for sex and age and corresponds to a body mass index equal to or greater than 30 or more for adults Body weight greater than 132 pounds (or 60 kg)